Saturday, November 29, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

AI Specialist Veritone Soars on Major Contract Wins and Upbeat Forecast

Dieter Jaworski by Dieter Jaworski
October 15, 2025
in AI & Quantum Computing, Earnings, Nasdaq, Tech & Software, Trading & Momentum
0
Veritone Stock
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

Veritone shares experienced a dramatic surge in after-hours trading following the announcement of substantial new contracts for its Data Refinery platform and an improved quarterly outlook. The stock skyrocketed 26.55% to $6.91, building significantly on the previous day’s advance of 9.64%.

Financial Performance and Market Reaction

The company released preliminary third-quarter results alongside its contract news, projecting revenue between $28.5 million and $28.7 million. This represents impressive growth of approximately 30.5% compared to the same period last year. While Veritone continues to anticipate an adjusted net loss ranging from $5.5 million to $6.0 million, this forecast shows modest improvement over previous guidance of $6.0 million to $6.5 million. The combination of robust revenue expansion, reduced projected losses, and major contract achievements fueled substantial investor optimism, reflected in the powerful after-hours rally.

Should investors sell immediately? Or is it worth buying Veritone?

Contract Momentum Drives Growth

Central to the bullish sentiment was Veritone’s disclosure of major agreements for its VDR solution. These recent contracts have propelled the company’s short-term pipeline and recent bookings to approximately $40 million, representing a dramatic doubling since August 2025. The Data Refinery platform specializes in converting unstructured data into actionable intelligence for training artificial intelligence models. Chief Executive Ryan Steelberg highlighted the company’s accelerating momentum, indicating that Veritone expects to formalize partnerships with nearly all major hyperscale cloud providers by the end of 2025.

Upcoming Catalyst in Focus

Market attention now turns to November 6, when Veritone will report complete third-quarter financial results. The critical test for the company will be demonstrating its capacity to convert the expanding Data Refinery pipeline into sustained revenue growth while continuing to narrow its losses. The current substantial share price movement indicates strong market approval of both the strategic contract victories and the improving financial trajectory for this artificial intelligence solutions provider.

Ad

Veritone Stock: Buy or Sell?! New Veritone Analysis from November 29 delivers the answer:

The latest Veritone figures speak for themselves: Urgent action needed for Veritone investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 29.

Veritone: Buy or sell? Read more here...

Tags: Veritone
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Owens, Minor Stock
Analysis

Owens & Minor Stock Faces Critical Support Test After Steep Decline

November 29, 2025
Celcuity Stock
Analysis

Celcuity Achieves Major Regulatory Milestone with FDA Submission

November 29, 2025
Azul Stock
Defense & Aerospace

Azul’s Financial Resilience: A Temporary Respite or Lasting Recovery?

November 29, 2025
Next Post
Corning Stock

Corning's Strategic Pivot Positions It for AI and Electric Vehicle Expansion

Thermo Fisher Scientific Stock

Wall Street Bullish on Thermo Fisher's Growth Trajectory

Broadcom Stock

Broadcom Emerges as Silent Powerhouse in Booming AI Hardware Sector

Recommended

Veterinary Industry stock Trading

Community Trust Bancorps FourthQuarter Earnings Report

2 years ago
Northern Oil & Gas Stock

Northern Oil & Gas Shares Plunge as Production Forecasts Dim

3 months ago
Amazon Stock

Amazon Shares Surge as Artificial Intelligence Fuels Cloud Revival

4 weeks ago

Analyst Upgrades Cardiff Oncology Stock with Higher Price Target

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Day One Biopharmaceuticals: Analysts Project 167% Upside Amid Institutional Accumulation

Is Jakks Pacific Stock Poised for a Dividend-Driven Rally?

Designer Brands: Can the Dividend Survive Mounting Financial Pressure?

Ethereum’s $3,000 Battle Line: Institutional Demand Clashes with Whale Selling

Ttec Shares: Can Expansion Strategy Reverse Declining Fortunes?

Seres Therapeutics Stock Approaches Critical Technical Juncture

Trending

Owens, Minor Stock
Analysis

Owens & Minor Stock Faces Critical Support Test After Steep Decline

by Felix Baarz
November 29, 2025
0

Owens & Minor shares continue to demonstrate significant weakness, posting another session of losses that brings the...

Celcuity Stock

Celcuity Achieves Major Regulatory Milestone with FDA Submission

November 29, 2025
Azul Stock

Azul’s Financial Resilience: A Temporary Respite or Lasting Recovery?

November 29, 2025
Day One Biopharmaceuticals Stock

Day One Biopharmaceuticals: Analysts Project 167% Upside Amid Institutional Accumulation

November 29, 2025
Jakks Pacific Stock

Is Jakks Pacific Stock Poised for a Dividend-Driven Rally?

November 29, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Owens & Minor Stock Faces Critical Support Test After Steep Decline
  • Celcuity Achieves Major Regulatory Milestone with FDA Submission
  • Azul’s Financial Resilience: A Temporary Respite or Lasting Recovery?

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com